← Back
$AKYA All transactions

Akoya Biosciences, Inc.

J

$ Value

Shares

947,688

Price

Filed

Jul 10

Insider

Name

McKelligon Brian

Title

President and CEO

CIK

0001857447

Roles

Director Officer

Transaction Details

Transaction Date

2025-07-08

Code

J

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Cashless exercise of options pursuant to that certain Amended and Restated Agreement and Plan of Merger dated as of April 28, 2025, as amended (the "Merger Agreement"), by and among Quanterix Corporation, a Delaware corporation ("Quanterix"), Wellfleet Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Quanterix ("Merger Sub"), and the Issuer. On July 8, 2025 (the "Closing Date"), Merger Sub merged with and into Issuer (the "Merger"), with Issuer surviving the Merger as a wholly owned subsidiary of Quanterix. | Pursuant to the Merger Agreement, as of the Closing Date, each outstanding option to purchase Issuer common stock was accelerated and each option with a per share exercise price less than the value of the Per Share Merger Consideration (as defined below) was automatically cashless exercised. | Disposition of shares pursuant to Merger Agreement. | In connection with the terms of the Merger Agreement, each share of common stock of Issuer outstanding on the Closing Date was converted into the right to receive (a) 0.1461 of a share of common stock of Quanterix (the "Per Share Stock Consideration") and (b) $0.38 in cash, without interest (the "Per Share Cash Consideration" and together with the Per Share Stock Consideration, the "Per Share Merger Consideration"). Each of the Per Share Stock Consideration and the Per Share Cash Consideration may be adjusted pursuant to the terms of the Merger Agreement. | Disposition of options pursuant to the Merger Agreement. | Pursuant to the Merger Agreement, as of the Closing Date, each outstanding option to purchase Issuer common stock was accelerated and each option with a per share exercise price equal to or greater than the Per Share Merger Consideration was automatically terminated and cancelled for no consideration.

Filing Info

Accession No.

0001062993-25-012730

Form Type

4

Issuer CIK

0001711933

McKelligon Brian's History

Date Ticker Type Value
2025-07-08 AKYA J
2025-07-08 AKYA J
2025-07-08 AKYA F
2025-07-08 AKYA J
2025-07-08 AKYA J $0
2025-07-08 AKYA J $0
2025-07-08 AKYA J $0
2025-07-08 AKYA J $0
2025-07-08 AKYA J $0
2025-07-08 AKYA J $0

Other Insiders at AKYA (90d)

No other insider activity at this issuer in the last 90 days.